Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth E Reczek

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Cancer Research : MCR|January 7, 2004
Multiple response elements and differential p53 binding control Perp expression during apoptosisElizabeth E Reczek, Elsa R Flores, Alice S Tsay, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2005
The NF1 tumor suppressor critically regulates TSC2 and mTORCory M Johannessen, Elizabeth E Reczek, Marianne F James, et al.
Nature|January 26, 2007
Restoration of p53 function leads to tumour regression in vivoAndrea Ventura, David G Kirsch, Margaret E McLaughlin, et al.
Cancer Cell|December 13, 2006
A negative feedback signaling network underlies oncogene-induced senescenceStéphanie Courtois-Cox, Sybil M Genther Williams, Elizabeth E Reczek, et al.
Infection and Immunity|March 28, 2018
Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular ImmunizationEdith Acquaye-Seedah, Elizabeth E Reczek, Hugh H Russell, et al.
Current Biology : CB|January 1, 2008
TORC1 is essential for NF1-associated malignanciesCory M Johannessen, Bryan W Johnson, Sybil M Genther Williams, et al.
Nature Medicine|February 16, 2010
An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaBJunxia Min, Alexander Zaslavsky, Giuseppe Fedele, et al.
Nature Medicine|February 21, 2024
Author Correction: An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κBJunxia Min, Alexander Zaslavsky, Giuseppe Fedele, et al.
Mabs|April 25, 2014
Non-viral adeno-associated virus-based platform for stable expression of antibody combination therapeuticsGwendolyn M Wilmes, Kimberly L Carey, Stuart W Hicks, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Cancer Research : MCR|January 7, 2004
Multiple response elements and differential p53 binding control Perp expression during apoptosisElizabeth E Reczek, Elsa R Flores, Alice S Tsay, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2005
The NF1 tumor suppressor critically regulates TSC2 and mTORCory M Johannessen, Elizabeth E Reczek, Marianne F James, et al.
Nature|January 26, 2007
Restoration of p53 function leads to tumour regression in vivoAndrea Ventura, David G Kirsch, Margaret E McLaughlin, et al.
Cancer Cell|December 13, 2006
A negative feedback signaling network underlies oncogene-induced senescenceStéphanie Courtois-Cox, Sybil M Genther Williams, Elizabeth E Reczek, et al.
Infection and Immunity|March 28, 2018
Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular ImmunizationEdith Acquaye-Seedah, Elizabeth E Reczek, Hugh H Russell, et al.
Current Biology : CB|January 1, 2008
TORC1 is essential for NF1-associated malignanciesCory M Johannessen, Bryan W Johnson, Sybil M Genther Williams, et al.
Nature Medicine|February 16, 2010
An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaBJunxia Min, Alexander Zaslavsky, Giuseppe Fedele, et al.
Nature Medicine|February 21, 2024
Author Correction: An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κBJunxia Min, Alexander Zaslavsky, Giuseppe Fedele, et al.
Mabs|April 25, 2014
Non-viral adeno-associated virus-based platform for stable expression of antibody combination therapeuticsGwendolyn M Wilmes, Kimberly L Carey, Stuart W Hicks, et al.
Pageof 1